Park West Asset Management LLC cut its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 17.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,946,191 shares of the company's stock after selling 414,987 shares during the period. Option Care Health comprises about 3.6% of Park West Asset Management LLC's investment portfolio, making the stock its 11th largest position. Park West Asset Management LLC owned about 1.14% of Option Care Health worth $45,152,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Wellington Management Group LLP raised its stake in Option Care Health by 84.6% during the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after acquiring an additional 8,400,208 shares in the last quarter. Norges Bank bought a new stake in shares of Option Care Health in the 4th quarter worth about $60,219,000. Dimensional Fund Advisors LP increased its position in shares of Option Care Health by 17.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock worth $92,518,000 after purchasing an additional 591,042 shares in the last quarter. Victory Capital Management Inc. increased its position in shares of Option Care Health by 31.1% during the 4th quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company's stock worth $49,310,000 after purchasing an additional 503,840 shares in the last quarter. Finally, Magnetar Financial LLC lifted its holdings in Option Care Health by 23.1% during the 4th quarter. Magnetar Financial LLC now owns 2,350,598 shares of the company's stock valued at $54,534,000 after purchasing an additional 441,265 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research firms have recently weighed in on OPCH. JMP Securities reaffirmed a "market outperform" rating and set a $36.00 price objective on shares of Option Care Health in a report on Tuesday, April 22nd. Barrington Research reiterated an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research report on Wednesday. UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $38.00 to $40.00 in a research note on Wednesday. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and raised their target price for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. Finally, JPMorgan Chase & Co. upped their price target on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. One analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, Option Care Health presently has a consensus rating of "Moderate Buy" and a consensus target price of $35.50.
Read Our Latest Research Report on Option Care Health
Insider Transactions at Option Care Health
In other news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company's stock, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.64% of the company's stock.
Option Care Health Trading Up 2.4 %
OPCH stock traded up $0.78 during midday trading on Friday, reaching $32.95. The stock had a trading volume of 3,358,100 shares, compared to its average volume of 1,827,653. The firm has a market cap of $5.41 billion, a price-to-earnings ratio of 27.69, a PEG ratio of 2.30 and a beta of 1.07. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The business has a fifty day simple moving average of $33.34 and a two-hundred day simple moving average of $28.83.
Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.04. The business had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The firm's revenue was up 16.3% on a year-over-year basis. During the same period last year, the company earned $0.26 EPS. As a group, research analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
See Also

Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.